Filter
166
Text search:
evaluation
des
risques
Featured
Recommendations
20
New Publications
48
Language
Document type
No document type
90
Guidelines
29
Studies & Reports
22
Manuals
9
Strategic & Response Plan
9
Training Material
3
Fact sheets
2
Situation Updates
1
Infographics
1
Countries / Regions
Congo, Democratic Republic of
22
Burkina Faso
15
Senegal
11
Madagascar
11
Benin
10
Haiti
8
Cameroon
5
Africa
4
Niger
3
Rwanda
3
West and Central Africa
3
Mali
2
Togo
2
Central African Republic
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Congo-Brazzaville
1
France
1
Authors & Publishers
Publication Years
Category
Countries
83
Clinical Guidelines
18
Women & Child Health
12
Key Resources
9
Public Health
4
Capacity Building
3
Pharmacy & Technologies
2
Toolboxes
Ebola & Marburg
10
COVID-19
9
Caregiver
9
Rapid Response
8
Mental Health
7
HIV
6
TB
5
2.0 Rapid Response
4
Disability
3
Conflict
3
AMR
3
Pharmacy
3
NTDs
3
Polio
2
Planetary Health
2
Malaria
2
Cholera
1
Natural Hazards
1
Refugee
1
Zika
1
Washington, D.C., ÉUA, du 23 au 27 septembre 2018
Point 8.3 de l'ordre du jour provisoire
CD56/INF/3 14 juillet 2018
Original: anglais
Version Révisée SEPTEMBRE 2016
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can be
...
Ce guide sur la tuberculose résistante est un outil pratique destiné à aider les agents de santé à prendre en charge le malade du point de vue clinique et opérationnel en mettant l’accent sur la décision thérapeutique, la mise en œuvre et le suivi du régime court de 9 mois pour le traite
...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
Lignes directrices.
Collection Avis et Rapports.
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy on vaccine safety, use of a network of distributed data
...
